Chemokine receptor interactions with virus-like particles

Methods in Molecular Biology

Volumn 1013, Issue , 2013, Pages 57-66

  Buonaguro, Luigi ^a   Tagliamonte, Maria ^a   Visciano, Maria Luisa ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell binding; CFSE labeling; Chemokine receptors; Human immunode ficiency virus; Virus like particles

Indexed keywords

CARBOXYFLUORESCEIN; CARBOXYFLUORESCEIN SUCCINIMIDYL ESTER; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLUTAMINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; SUCCINIMIDE DERIVATIVE; VIRUS LIKE PARTICLE VACCINE;

ARTICLE; CELL LABELING; CELL VIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INSECT CELL CULTURE; MOLECULAR WEIGHT; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN INTERACTION; TUMOR CELL; VIRUS ENTRY; VIRUS LIKE AGENT; ANIMAL; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; PROTEIN BINDING; SF9 CELL; TIME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FLUORESCEINS; FLUORESCENT DYES; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; RECEPTORS, CHEMOKINE; SF9 CELLS; SUCCINIMIDES; TIME FACTORS; TRANSFECTION; VACCINES, VIRUS-LIKE PARTICLE; VIRUS INTERNALIZATION;

EID: 84886822983     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-426-5_5     Document Type: Article

References (36)

1. Doms RW, Moore JP (2000) HIV-1 membrane fusion: targets of opportunity. J Cell Biol 151:F9-F14
2. Jones PL, Korte T, Blumenthal R (1998) Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J Biol Chem 273:404-409
3. Sullivan N, Sun Y, Sattentau Q, Thali M, Wu D, Denisova G et al (1998) CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J Virol 72:4694-4703
4. Sattentau QJ, Moore JP (1991) Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 174:407-415
5. Zhang W, Canziani G, Plugariu C, Wyatt R, Sodroski J, Sweet R et al (1999) Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 38: 9405-9416
6. Wyatt R, Sodroski J (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888
7. Golding H, Zaitseva M, de Rosny E, King LR, Manischewitz J, Sidorov I et al (2002) Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J Virol 76:6780-6790
8. Eckert DM, Kim PS (2001) Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 70:777-810
9. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP et al (2004) HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5:233-236
10. Schulke N, Vesanen MS, Sanders RW, Zhu P, Lu M, Anselma DJ et al (2002) Oligomeric and conformational properties of a proteolytically mature, disul fi de-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J Virol 76:7760-7776
11. Srivastava IK, VanDorsten K, Vojtech L, Barnett SW, Stamatatos L (2003) Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus nvelope constructs upon partial deletion of the second hypervariable region. J Virol 77:2310-2320
12. Yang X, Lee J, Mahony EM, Kwong PD, Wyatt R, Sodroski J (2002) Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fi britin. J Virol 76:4634-4642
13. Grundner C, Mirzabekov T, Sodroski J, Wyatt R (2002) Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins. J Virol 76:3511-3521
14. Race E, Frezza P, Stephens DM, Davis D, Polyanskaya N, Cranage M et al (1995) An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses. Vaccine 13:54-60
15. Buonaguro L, Buonaguro FM, Tornesello ML, Mantas D, Beth-Giraldo E, Wagner R et al (2001) High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antivir Res 49:35-47
16. Crooks ET, Moore PL, Franti M, Cayanan CS, Zhu P, Jiang P et al (2007) A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366: 245-262
17. Gheysen D, Jacobs E, de Foresta F, Thiriart C, Francotte M, Thines D et al (1989) Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59: 103-112
18. Delchambre M, Gheysen D, Thines D, Thiriart C, Jacobs E, Verdin E et al (1989) The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J 8:2653-2660
19. Miyanohara A, Imamura T, Araki M, Sugawara K, Ohtomo N, Matsubara K (1986) Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons. J Virol 59:176-180
20. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 89:12180-12184
21. Takamura S, Niikura M, Li TC, Takeda N, Kusagawa S, Takebe Y et al (2004) DNA vaccine- encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther 11:628-635
22. Malboeuf CM, Simon DA, Lee YE, Lankes HA, Dewhurst S, Frelinger JG et al (2007) Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine 25: 3270-3276
23. Touze A, Coursaget P (1998) In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res 26:1317-1323
24. Xu YF, Zhang YQ, Xu XM, Song GX (2006) Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes. Arch Virol 151:2133-2148
25. Buonaguro L, Buonaguro FM, Tornesello ML (2010) Virus-like particles as particulate vaccines. Curr HIV Res 8:299-309
26. Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T et al (2002) Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 76:9335-9344
27. Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R et al (2006) Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 80:9134-9143
28. Visciano ML, Diomede L, Tagliamonte M, Tornesello ML, Asti V, Bomsel M et al (2011) Generation of HIV-1 virus-like particles expressing different HIV-1 glycoproteins. Vaccine 29:4903-4912
29. Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L (2011) Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies. J Transl Med 9(Suppl 1):S1
30. Harrison RL, Jarvis DL (2007) Transforming lepidopteran insect cells for continuous recombinant protein expression. Methods Mol Biol 388:299-316
31. Jarvis DL, Fleming JA, Kovacs GR, Summers MD, Guarino LA (1990) Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Biotechnology (NY) 8:950-955
32. Kato T, Murata T, Usui T, Park EY (2004) Comparative analysis of GFP(UV)-beta1,3-Nacetylglucosaminyltransferase 2 production in two insect-cell-based expression systems. Protein Expr Purif 35:54-61
33. Weston SA, Parish CR (1990) New fl uorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 133:87-97
34. Lyons AB, Parish CR (1994) Determination of lymphocyte division by flow cytometry. J Immunol Methods 171:131-137
35. Drobni P, Mistry N, McMillan N, Evander M (2003) Carboxy- fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-likeparticles fl uoresce after internalization and interact with heparan sulfate for binding and entry. Virology 310:163-172
36. Bergsdorf C, Beyer C, Umansky V, Werr M, Sapp M (2003) Highly efficient transport of carboxy fluorescein diacetate succinimidyl ester into COS7 cells using human papillomavirus-like particles. FEBS Lett 536: 120-124